March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Immune Response in Meibomian Gland Dysfunction (MGD) and the Effect of Anti-Inflammatory Therapy: An In Vivo Confocal Microscopy (IVCM) Study
Author Affiliations & Notes
  • Yureeda Qazi
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Bernardo Cavalcanti
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Andrea Cruzat
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Susan Cheng
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Candice Williams
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Monique Trinidad
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Deborah Witkin
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Caroline A. Blackie
    TearScience, Boston, Massachusetts
  • Donald R. Korb
    Korb Associates, Boston, Massachusetts
  • Pedram Hamrah
    Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
    Immune Disease Institute, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Yureeda Qazi, None; Bernardo Cavalcanti, None; Andrea Cruzat, None; Susan Cheng, None; Candice Williams, None; Monique Trinidad, None; Deborah Witkin, None; Caroline A. Blackie, TearScience (I, E); Donald R. Korb, TearScience (F, I, P); Pedram Hamrah, None
  • Footnotes
    Support  NIH K08-EY020575, New England Corneal Transplant Research Fund
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 593. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yureeda Qazi, Bernardo Cavalcanti, Andrea Cruzat, Susan Cheng, Candice Williams, Monique Trinidad, Deborah Witkin, Caroline A. Blackie, Donald R. Korb, Pedram Hamrah; Immune Response in Meibomian Gland Dysfunction (MGD) and the Effect of Anti-Inflammatory Therapy: An In Vivo Confocal Microscopy (IVCM) Study. Invest. Ophthalmol. Vis. Sci. 2012;53(14):593.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze the host immune response and effects of anti-inflammatory treatment in MGD using laser in vivo confocal microscopy (IVCM).

Methods: : IVCM (HRT3/RCM, Heidelberg Engineering) images of the palpebral conjunctiva and meibomian glands (MG) acquired from one eye of 5 healthy individuals, and both eyes of 11 patients with clinical diagnosis of MGD were analyzed. All participants had an ocular surface exam and symptom assessment using the Ocular Surface Disease Index (OSDI) questionnaire, followed by imaging, at initial and follow-up visits. Anti-inflammatory treatment was prescribed based on IVCM findings, and 6 patients had follow-up visits. Images were analyzed for inflammatory cell and acinar density of the conjunctiva and MGs. Fifteen parameters were evaluated and 3 images per parameter were analyzed. Student’s t-test and linear correlations were used for statistical analysis.

Results: : Compared to normals, patients with MGD had significant conjunctival epithelial inflammation (576 ± 285 vs. 278 ± 203 cells/ mm2, p=0.03), thicker, more globular acinar epithelium (19 ± 3 vs. 15 ± 3µm, p=0.04), with possible trends towards higher intraglandular inflammation (55 ± 23 vs. 35 ± 26%, p=0.3), lower acinar density (76 ± 43 vs. 127 ± 48 acini/mm2, p=0.08) and greater corneal staining (grade 1 ± 0.7 vs. 0, p=0.07). After anti-inflammatory treatment, patients demonstrated markedly reduced epithelial, stromal and intraglandular inflammation (162 ± 191 vs. 576 ± 285 cells/ mm2 p=0.003; 17 ± 23 vs. 118 ± 139 cells/ mm2 p=0.04; 19 ± 12 vs. 55 ± 23% p=0.01 respectively), with improved TBUT (8 ± 1s vs. 5 ± 2s, p=0.01) and a possible trend towards improved corneal fluorescein staining (0.6 ± 0.5 vs. 1 ± 0.7; p=0.2). TBUT correlated negatively with epithelial and stromal inflammation (r=-0.3, -0.4, n=20), and corneal staining negatively with acinar density (r=-0.6, n=9). Interestingly, while clinical and imaging parameters improved on first follow-up, symptoms did not; OSDI displayed a trend for improvement only on subsequent follow-up (28 ± 22 vs. 40 ± 13, p=0.3).

Conclusions: : IVCM demonstrates that MGD is associated with increased conjunctival and intraglandular inflammation. Anti-inflammatory therapy improves both clinical signs and imaging parameters, but is followed by a lag in symptomatic relief.

Keywords: cornea: tears/tear film/dry eye • inflammation • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×